Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

NCT: NCT06893588 · RECRUITING

NCT IDNCT06893588
StatusRECRUITING
Start Date2025-04-14
Completion2027-03-15

Brief Summary

A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)

Frequently Asked Questions

What is Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts?

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts is a clinical trial registered under NCT06893588. Current status: RECRUITING.

What is the status of NCT06893588?

The current status of NCT06893588 (Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts) is: RECRUITING.

When did Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts start?

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts started on 2025-04-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑